Abstract:The risk of developing Alzheimer's disease (AD) is almost double in patients with insulin resistance. Prolong hyperinsulinemia is a major cause of insulin resistance. We presented in last year that peripheral hyperinsulinemia and insulin resistance alters the biology and function in neurons at early stages. Mechanistically, we showed that failure of prompt glucose metabolism due to loss of hexokinase-2 (HK2) impairs a multi-step pathway that results in reactivation of cell cycle machinery, as well as accumulation of signals of phosphorylated tau and amyloid. Despite all these cellular findings, it is important to address these series of events in vivo, and their consequences on animal behavior. Assays including behavioral analyses in young (3-month) versus aged (22-44 month) wild type mice (N=24) were performed. Stereotaxic injections of adeno-associated virus (AAV) that carries shRNA against HK2 were performed in hippocampal CA1 region of young non-insulin resistant wildtype mice. Behavioral, immunohistochemistry and a variety of cellular and biochemistry methods were performed to analyze changes occurred in these animals. Here we report that insulin resistant neurons eventually become senescent, a consequence of aberrant reactivation of cell cycle machinery. At behavioral level, insulin resistant animals showed cognitive decline and memory impairment, both were inter-correlated to the severity of peripheral insulin resistance and the senescent load in the brain. Mechanistically, the importance of neuronal glycolysis was validated in vivo. Similar behavioral changes were recapitulated in young non-insulin resistant animals with HK2 knockdown in CA1 neurons. Notably, these neurons also showed aberrant cell cycle re-activation and expressed a senescent phenotype. These findings therefore extended our understanding on how peripheral hyperinsulinemia and insulin resistance alters the biology and function of the brain, particularly at behavioral levels. At basic science level, our data also offer a mechanism on how post-mitotic neurons could become senescent—an outcome of aberrant cell cycle reactivation. At translational level, this study re-emphasizes that metabolic syndrome like peripheral insulin resistance is a modifiable risk factor for AD. Better management of insulin resistance is therefore a important strategy to prevent related neurodegeneration events and potential initiation of AD.

Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model

Enhancement of Β-Amyloid Oligomer Accumulation after Intracerebroventricular Injection of Streptozotocin, Which Involves Central Insulin Signaling in a Transgenic Mouse Model

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.

Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.

Deregulation of Brain Insulin Signaling in Alzheimer’s Disease

Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway

Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model

Insulin aggravates amyloid deposition and cognition impairment in an AD-like rat model

Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.

Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer’s Rat Model

Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation

Insulin Signaling in Sporadic Alzheimer's Disease.

Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model

219-OR: Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aß and Neuroinflammatory Response Exacerbating Alzheimer-Like Neuropathology

INSULIN RESISTANT NEURONS ARISEN FROM PERIPHERAL HYPERINSULINEMIA ARE SENESCENT AND CORRELATE WITH MEMORY IMPAIRMENT AND COGNITIVE DECLINE: IMPLICATIONS FOR ALZHEIMER’S DISEASE

Loss of Insulin Signaling in Microglia Impairs Cellular Uptake of Aβ and Neuroinflammatory Response Exacerbating Alzheimer-like Neuropathology

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin

Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer’s disease: possible mechanisms of IDE in T2D and AD

Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity